| Host: | Mouse |
| Applications: | CLIA/FIA |
| Reactivity: | Human |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Mouse monoclonal anti-PINP for use in CLIA and FIA in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Clonality : | Monoclonal |
| Clone ID : | 11502 |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Formulation: | 50 mM citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Concentration: | 5.0 mg/ml (+/-10 %) |
| Storage Instruction: | Store at 2–8 °C, and do not freeze. |
| Specificity: | Antibody recognizes intact form of human procollagen I N-terminal peptide. Not determined |
| Immunogen: | Not determined |
| Background | Amino-terminal propeptide of type I procollagen (PINP) is released into blood circulation during bone formation. PINP is used as a bone turnover marker for the assessment of fracture risk and monitoring of osteoporosis treatment. PINP is recommended as reference bone formation marker by IOF and IFCC1. |
Information sourced from Uniprot.org